Technology Industry

Industry: Email Alert RSS Feed

MacWeek

View more issues:

Articles in Feb 16, 1998 issue of MacWeek

advertisement

Brought to you by CBS MoneyWatch.com

advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here
  • Your Work MLB's Rev-Share Formula

    MLB's Rev-Share Formula

    MLB’s revenue-sharing program prevents large-market teams, like the Yankees and Red Sox, from dominating the league every year. Here's how the program affects revenues, payroll, and the competitive balance of baseball.

  • Your Industry Biogen Corners the Social-Media Market For Its Drugs

    Biogen Corners the Social-Media Market For Its Drugs

    On November 2, Biogen Idec updated the prescribing label for its blockbuster multiple sclerosis drug Tysabri (natalizumab) after consultation with the FDA. Aside from acknowledging that the risk of developing progressive multifocal leukoencephalopathy (PML), an often fatal brain infection, increases with longer duration of treatment, no other revisions concerning the risk of PML were required. The fact that this biologic remains a cornerstone treatment for adult patients with relapsing forms of MS -- only the second drug to ever return to U.S. pharmacy shelves after having been withdrawn -- speaks volumes to the growing influence of the worldwide web.

  • Your Money Health Insurance: Is AARP Looking Out For You?

    Health Insurance: Is AARP Looking Out For You?

    AARP’s health and long-term-care insurance policies are rarely the cheapest option, but they are surprisingly competitive, and can be particularly good for people who are not in perfect health. MoneyWatch compared benefits and real-world prices to find the best plans for you.